Axsome Therapeutics, Inc. Q4 Loss Decreases, But Misses Estimates

(RTTNews) - Axsome Therapeutics, Inc. (AXSM) released Loss for fourth quarter that decreased from the same period last year but missed the Street estimates.

The company's earnings came in at -$74.91 million, or -$1.54 per share. This compares with -$98.65 million, or -$2.08 per share, last year.

Analysts on average had expected the company to earn -$1.00 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 66.0% to $118.77 million from $71.53 million last year.

Axsome Therapeutics, Inc. earnings at a glance (GAAP) :

-Earnings: -$74.91 Mln. vs. -$98.65 Mln. last year. -EPS: -$1.54 vs. -$2.08 last year. -Revenue: $118.77 Mln vs. $71.53 Mln last year.